Different effects of soluble and aggregated amyloid β42 on gene/protein expression and enzyme activity involved in insulin and APP pathways

被引:13
作者
Bartl J. [1 ]
Meyer A. [1 ]
Brendler S. [1 ]
Riederer P. [1 ]
Grünblatt E. [1 ,2 ]
机构
[1] Department of Psychiatry, Psychosomatics and Psychotherapy, University Hospital of Würzburg, Würzburg
[2] Hospital of Child and Adolescent Psychiatry, University of Zurich, Zurich
关键词
Alzheimer's dementia; GSK3β; Insulin receptor; MAO-B; Soluble/aggregated Aβ42;
D O I
10.1007/s00702-012-0852-5
中图分类号
学科分类号
摘要
Although Alzheimer's dementia (AD) is not characterised any longer simply as the accumulation and deposition of amyloid beta (Aβ) peptides and hyperphosphorylation of tau proteins within the brain, excessive Aβ42 deposition is still considered to play a major role in this illness. Aβ are able to adopt many differently aggregate forms, including amyloid fibrils as well as nonfibrillar structures (soluble Aβ42 oligomers). It is not well-established that which Aβ42 state is most responsible for AD or why. We wanted to verify which effects Aβ42 oligomers and aggregated peptides have on gene expression, protein level and enzyme activity of insulin and amyloid precursor protein (APP) pathways in vitro. Human neuroblastoma cells (SH-SY5Y) were treated with varying concentrations of soluble and aggregated Aβ42. Treatment effects on β-secretase (BACE), glycogen synthase kinase 3α (GSK3α), glycogen synthase kinase 3β (GSK3β), phosphatidylinositol-3 kinase (PI-3K), insulin-degrading enzyme (IDE), insulin-receptor substrate 1 (IRS1), insulin receptor (INSR) and monoamine oxidase B (MAO-B) were investigated via quantitative-PCR, western blot, ELISA and enzyme activity assay. We could find different effects of soluble and aggregated peptides especially on gene/protein expression of GSK3β and INSR and on GSK3β and MAO-B activity. Soluble peptides showed significant effects leading to increased gene expression and protein amount of GSK3β and to decreased level of gene and protein expression of INSR. MAO-B activity was enhanced after treatment with aggregated peptides and strongly inhibited after soluble Aβ42 treatment. Our data might provide insights into selective effects of specific forms of Aβ42 aggregates in AD. © 2012 Springer-Verlag.
引用
收藏
页码:113 / 120
页数:7
相关论文
共 39 条
[1]  
Balaraman, Y., Limaye, A.R., Levey, A.I., Srinivasan, S., Glycogen synthase kinase 3β and Alzheimer's disease: Pathophysiological and therapeutic significance (2006) Cellular and Molecular Life Sciences, 63 (11), pp. 1226-1235. , DOI 10.1007/s00018-005-5597-y
[2]  
Barnes, D.E., Covinsky, K.E., Whitmer, R.A., Kuller, L.H., Lopez, O.L., Yaffe, K., Commentary on "developing a national strategy to prevent dementia: Leon Thal Symposium 2009." Dementia risk indices: A framework for identifying individuals with a high dementia risk (2010) Alzheimers Dement, 6, pp. 138-141. , 20298975 10.1016/j.jalz.2010.01.005
[3]  
Bartl, J., Monoranu, C.M., Wagner, A.K., Kolter, J., Riederer, P., Grunblatt, E., Alzheimer's disease and type 2 diabetes: Two diseases, one common link? (2012) World J Biol Psychiatry
[4]  
Benilova, I., Karran, E., De Strooper, B., The toxic Abeta oligomer and Alzheimer's disease: An emperor in need of clothes (2012) Nat Neurosci, 15, pp. 349-357. , 22286176 10.1038/nn.3028 1:CAS:528:DC%2BC38XhtlOltrc%3D
[5]  
Biedler, J.L., Roffler-Tarlov, S., Schachner, M., Freedman, L.S., Multiple neurotransmitter synthesis by human neuroblastoma cell lines and clones (1978) Cancer Research, 38 (11), pp. 3751-3757
[6]  
Brunet, A., Datta, S.R., Greenberg, M.E., Transcription-dependent and -independent control of neuronal survival by the PI3K-Akt signaling pathway (2001) Current Opinion in Neurobiology, 11 (3), pp. 297-305. , DOI 10.1016/S0959-4388(00)00211-7
[7]  
Crouch, P.J., Harding, S.-M.E., White, A.R., Camakaris, J., Bush, A.I., Masters, C.L., Mechanisms of Aβ mediated neurodegeneration in Alzheimer's disease (2008) International Journal of Biochemistry and Cell Biology, 40 (2), pp. 181-198. , DOI 10.1016/j.biocel.2007.07.013, PII S1357272507002518
[8]  
Dahlgren, K.N., Manelli, A.M., Blaine Stine Jr., W., Baker, L.K., Krafft, G.A., Ladu, M.J., Oligomeric and fibrillar species of amyloid-β peptides differentially affect neuronal viability (2002) Journal of Biological Chemistry, 277 (35), pp. 32046-32053. , DOI 10.1074/jbc.M201750200
[9]  
De Felice, F.G., Wu, D., Lambert, M.P., Fernandez, S.J., Velasco, P.T., Lacor, P.N., Bigio, E.H., Klein, W.L., Alzheimer's disease-type neuronal tau hyperphosphorylation induced by Aβ oligomers (2008) Neurobiology of Aging, 29 (9), pp. 1334-1347. , DOI 10.1016/j.neurobiolaging.2007.02.029, PII S019745800700108X
[10]  
De La Monte, S.M., Longato, L., Tong, M., Wands, J.R., Insulin resistance and neurodegeneration: Roles of obesity, type 2 diabetes mellitus and non-alcoholic steatohepatitis (2009) Curr Opin Investig Drugs, 10, pp. 1049-1060. , 19777393